| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
54,589 | 55,232 | 98,427 | 90,122 | 92,055 |
| Cost of Revenue
|
0 | 0 | -30,686 | -33,768 | -21,635 |
|
Gross Profit
|
55,232 | 55,232 | 67,741 | 56,354 | 70,420 |
| Selling, General and Administrative Expenses
|
-53,459 | -68,673 | -76,751 | -77,417 | -92,333 |
|
Research and Development Expenses
|
-131,773 | -117,330 | -120,908 | -114,162 | -218,323 |
|
Operating Income/Expenses
|
-185,232 | -186,003 | -197,659 | -191,579 | -310,656 |
|
Total Operating Profit/Loss
|
-130,643 | -130,771 | -129,918 | -135,225 | -240,236 |
| Total Net Finance Income/Expense
|
-11,781 | -15,746 | -13,612 | -6,325 | -22,128 |
| Net Investment Income
|
-- | -- | -- | 0 | 33,427 |
| Irregular Income/Expenses
|
-10,089 | -9,331 | 24,720 | -128,459 | -135,930 |
|
Other Income/Expense, Non-Operating
|
-601 | 361 | -390 | -6,247 | -116 |
|
Non-Operating Income/Expenses, Total
|
-22,471 | -24,716 | 10,718 | -141,031 | -124,747 |
|
Pretax Income
|
-153,114 | -155,487 | -119,200 | -276,256 | -364,983 |
|
Provision for Income Tax
|
-64 | 138 | 239 | 200 | -3,215 |
|
Earnings from Equity Interest, Post-Tax
|
-3,949 | -8,727 | 0 | -- | -- |
|
Net Income from Continuing Operations
|
-157,127 | -164,076 | -118,961 | -276,056 | -368,198 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-157,127 | -164,076 | -118,961 | -276,056 | -368,198 |
|
Net Income after Non-Controlling/Minority Interests
|
-157,127 | -164,076 | -118,961 | -276,056 | -368,198 |
|
Net Income Available to Common Stockholders
|
-157,127 | -164,076 | -118,961 | -276,056 | -368,198 |
|
Diluted Net Income Available to Common Stockholders
|
-157,127 | -164,076 | -118,961 | -276,056 | -368,198 |
| Basic EPS
|
-2.87 | -9.73 | -8.68 | -21.75 | -29.55 |
| Diluted EPS
|
-2.87 | -9.73 | -8.68 | -21.75 | -29.55 |
|
Basic Weighted Average Shares Outstanding
|
24,292.88 | 16,870.93 | 13,710.78 | 12,666.73 | 12,475.87 |
|
Diluted Weighted Average Shares Outstanding
|
24,292.88 | 16,870.93 | 13,710.78 | 12,666.73 | 12,475.87 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-141,333 | -139,741 | -105,588 | -269,931 | -342,855 |
|
EBITDA
|
-140,640 | -138,715 | -101,197 | -262,116 | -329,825 |
|
Normalized EBITDA
|
-118,566 | -116,735 | -104,305 | -95,170 | -170,002 |
|
Normalized Income
|
-139,688.54 | -142,117.98 | -122,062.78 | -109,175.48 | -241,937.83 |
|
Total Unusual Items
|
22,074 | 21,980 | -3,108 | 166,946 | 159,823 |
12/31/2022 - 5/3/1994
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade